Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.

The delta opioid system is involved in the behavioral effects of various drugs of abuse. However, only a few studies have focused on the possible interactions between the opioid system and the effects of 3,4-methylenedioxymethamphetamine (MDMA). In order to examine the possible role of the delta opioid system in MDMA-induced behaviors in mice, locomotor activity and conditioned place preference (CPP) were investigated in the presence of naltrindole (NTI), a selective delta opioid antagonist. Moreover, the consequences of acute and chronic MDMA administration on pro-enkephalin (Penk) and pro-opiomelanocortin (Pomc) gene expression were assessed by real-time quantitative polymerase chain reaction (QPCR). The results showed that, after acute MDMA administration (9 mg/kg; i.p.), NTI (5 mg/kg, s.c.) was able to totally block MDMA-induced hyperlocomotion. Penk gene expression was not modulated by acute MDMA, but a decrease of Pomc gene expression was observed, which was not antagonized by NTI. Administration of the antagonist prevented the acquisition of MDMA-induced CPP, suggesting an implication of the delta opioid receptors in this behavior. Following chronic MDMA treatment, only the level of Pomc was modulated. The observed increase was totally blocked by NTI pre-treatment. All these results confirm the interactions between the delta opioid system (receptors and peptides) and the effects of MDMA.

Mots clés

conditioned place preference gene expression locomotor activity MDMA opioid system striatum

Domaines

Génomique, Transcriptomique et Protéomique [q-bio.GN]

Fichier principal

figure_1_a_b_c.pdf (21.88 Ko)

Figure_2.pdf (11.28 Ko)

Figure_3_a_b.pdf (16.16 Ko)

Figure_4.pdf (10.84 Ko)

Figure_5_a_b.pdf (18.03 Ko)

article_MDMA_v30janv09.pdf (200.88 Ko)

inserm-00416565_edited.pdf (327.6 Ko)

Origine : Fichiers produits par l'(les) auteur(s)

Cynthia Marie-Claire : Connectez-vous pour contacter le contributeur

https://inserm.hal.science/inserm-00416565

Soumis le : lundi 5 juillet 2010-09:35:25

Dernière modification le : vendredi 19 avril 2024-16:18:56

Archivage à long terme le : mercredi 30 novembre 2016-10:02:46

Dates et versions

inserm-00416565 , version 1 (05-07-2010)

Identifiants

HAL Id : inserm-00416565 , version 1
DOI : 10.1111/j.1369-1600.2009.00156.x
PUBMED : 19523041

Citer

Emilie Belkaï, Jean-Michel Scherrmann, Florence Noble, Cynthia Marie-Claire. Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.. Addiction Biology, 2009, 14 (3), pp.245-52. ⟨10.1111/j.1369-1600.2009.00156.x⟩. ⟨inserm-00416565⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM IRD UNIV-PARIS7 ENSCP CNRS IFR71 U705 PARISTECH PSL

329 Consultations

573 Téléchargements